empty
 
 
id
Cari
Bantuan
Pembukaan akun instan
Platform Trading
Deposit/Penarikan
Cari
P2P Pertukaran Pasar Keuangan Untuk Kitra Forum Tentang perusahaan
id
Untuk Trader
Grafik
#ALNY

#ALNY (Alnylam Pharmaceuticals Inc.). Nilai tukar dan grafik online.

#ACB Kembali ke daftar instrumen #AMGN

Konverter mata uang

Alnylam Pharmaceuticals Inc.
252.47 USD
26 Nov 2024 22:59
Perubahan Harga (% chg)
$-0.24
(-0.1%)
Penutupan Sebelumnya
Penutupan Sebelumnya

Harga penutupan, hari sebelumnya.
$250.7
Buka
Buka

Harga pembukaan.
$243.83
Ketinggian Harian
Ketinggian Harian

Harga tertinggi pada hari transaksi terakhir.
$253.35
Kerendahan Harian
Kerendahan Harian

Harga terendah pada hari transaksi terakhir
$247.95
Kapitalisasi pasar
Kapitalisasi pasar

Nilai total perusahaan dalam pasar saham. Umumnya dihitung dengan menggandakan saham-saham yang beredang dengan harga saham saat itu.
$253.35
Saham Beredar
Saham Beredar

Jumlah saham yang dipegang oleh para investor dan insider perusahaan, diluar sekuritas dilutif (dilutive securities) seperti non-vested RSU dan unexercised options.
$229.27
Unduh arsip
Beli
252.47
Jual
252.47
Buka tabel dalam tampilan layar penuh
Beli
252.47
Jual
252.47
Unduh arsip
Buka tabel dalam tampilan layar penuh

Alnylam Pharmaceuticals Inc. About company

Alnylam Pharmaceuticals Inc. is an American biopharmaceutical company, founded in 2002. The firm is mainly involved in the research and development of drugs for treating genetic disorders.

In 2016, Alnylam Pharmaceuticals Inc. was added to the Forbes list of the world’s 100 most innovative growth companies.

This year, the market capitalization of Alnylam Pharmaceuticals Inc. totals $17.65 billion. In 2021, it raised revenue of $844.29 million. In the first six months of 2022, the company earned as much as $224.82 million.

Alnylam Pharmaceuticals Inc.’s shares and factors shaping their value

The company has been listed on the NASDAQ exchange since 2004 under the ALNY ticker. Its share value currently totals $200-205. Over the past 12 months, ALNY has fluctuated in the range of $117 to $236.

When trading the firm’s stock, you should pay attention to the following factors:

  • The company has a heavy dependence on the state of the healthcare sector as a whole. Thus, new COVID outbreaks have a negative influence on its revenue growth;
  • The company occasionally introduces new drugs to the market, conducting clinical and laboratory trials and publishing the results beforehand;
  • Constantly growing revenues are the firm’s advantage;
  • Enough own funds to finance projects without the need to additionally issue securities.

Tidak bisa bicara sekarang?
Tanyakan pertanyaan anda lewat chat.